直肠癌患者常规放疗实践中侧方淋巴结覆盖情况及与局部复发率的关系
该研究从荷兰2016年全国横断面研究中选取原发肿瘤距肛直肠交界≤8 cm、cT3-4期且至少1枚髂内或闭孔侧方淋巴结短径≥5 mm并接受新辅助放化疗的直肠癌患者,审查MRI与放疗计划中侧方淋巴结的覆盖情况及相关局部复发率,发现侧方淋巴结 adequate 覆盖仍伴随相当的4年局部复发率,需进一步探索改善局部控制的技术。
要点
- 223/3057例患者至少1枚侧方淋巴结短径≥5 mm,其中180枚(80.7%)位于临床靶区内,60枚(33.3%)被勾画为大体肿瘤体积。
- 202枚侧方淋巴结(90.6%)接受≥95%计划放疗剂量。
- 侧方淋巴结位于临床靶区外与位于靶区内的4年局部复发率分别为4.0%与12.5%(P=0.092),未达统计学显著。
核心结论
- 对常规放疗实践的评估显示,侧方淋巴结的 adequate 覆盖仍与相当的4年局部复发率相关,需要进一步探索能为侧方淋巴结受累患者带来更好局部控制的技术。
研究设计与样本
- 从荷兰2016年治疗的直肠癌患者全国横断面研究中选取原发肿瘤距肛直肠交界≤8 cm、cT3-4期且至少1枚髂内或闭孔侧方淋巴结短轴≥5 mm并接受新辅助放化疗的患者。
- 共纳入223/3057例患者,审查磁共振图像与放疗治疗计划中侧方淋巴结是否被勾画为大体积肿瘤、是否位于临床靶区内及接受计划放疗剂量的比例。
主要发现
- 180枚(80.7%)侧方淋巴结位于临床靶区内,其中60枚(33.3%)被勾画为大体积肿瘤。
- 202枚(90.6%)侧方淋巴结接受≥95%的计划放疗剂量。
- 侧方淋巴结位于临床靶区外与位于靶区内的4年局部复发率分别为4.0%与12.5%(P=0.092),未达统计学显著。
- 接受<95%与≥95%计划放疗剂量的4年局部复发率分别为7.1%与11.3%(P=0.843),未达统计学显著。
- 接受60 Gy剂量递增的7例患者中2例发生局部复发,4年局部复发率为28.6%。
局限性
- 原文结论指出需要进一步探索能为侧方淋巴结受累患者带来更好局部控制的技术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Involved internal iliac and obturator lateral lymph nodes (LLNs) are a known risk factor for the occurrence of ipsilateral local recurrences (LLR) in rectal cancer. This study examined coverage of LLNs with routine radiation therapy practice in the Netherlands and associated LLR rates. METHODS AND MATERIALS: Patients with a primary tumor ≤8 cm of the anorectal junction, cT3-4 stage, and at least 1 internal iliac or obturator LLN with short axis ≥5 mm who received neoadjuvant (chemo)radiation therapy, were selected from a national, cross-sectional study of patients with rectal cancer treated in the Netherlands in 2016. Magnetic resonance images and radiation therapy treatment plans were reviewed regarding segmented LLNs as gross tumor volume (GTV), location of LLNs within clinical target volume (CTV), and received proportion of the planned radiation therapy dose. RESULTS: A total of 223 out of 3057 patients with at least 1 LLN ≥5 mm were selected. Of those, 180 (80.7%) LLNs were inside the CTV, of which 60 (33.3%) were segmented as GTV. Overall, 202 LLNs (90.6%) received ≥95% of the planned dose. Four-year LLR rates were not significantly higher for LLNs situated outside the CTV compared with those inside (4.0% vs 12.5%, P = .092) or when receiving <95% versus ≥95% of the planned radiation therapy dose (7.1% vs 11.3%, P = .843), respectively. Two of 7 patients who received a dose escalation of 60 Gy developed an LLR (4-year LLR rate of 28.6%). CONCLUSIONS: This evaluation of routine radiation therapy practice showed that adequate coverage of LLNs was still associated with considerable 4-year LLR rates. Techniques resulting in better local control for patients with involved LLNs need to be explored further.
引用
- Sluckin TC, Hazen SJA, Horsthuis K, et al. Coverage of Lateral Lymph Nodes in Rectal Cancer Patients with Routine Radiation Therapy Practice and Associated Locoregional Recurrence Rates. Int J Radiat Oncol Biol Phys. 2023. PMID: 37120027. doi:10.1016/j.ijrobp.2023.04.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。